Cytoprotective effects of adrenomedullin in glomerular cell injury: Central role of cAMP signaling pathway. Activation of cAMP signaling pathway was shown to inhibit some pathohiologic processes in mesangial cells (MC). We investigated whether adrenomedullin (ADM), a potent agonist of adenylate cyclase, is synthesized in MC and whether it can, via cAMP, suppress the generation of reactive oxygen metabolites (RUM) and proliferation of cells in glomeruli. With the use of an immunohistologic technique ADM was detected in mesangial and microvascular areas of rat glomeruli. MC grown in primary culture synthesized ADM, and the synthesis was stimulated by TNFa and 1L-1 but not by PDGF and EGF. ADM inhibited RUM generation in MC dose-dependently and caused in situ activation of protein kinase A (PKA). In macrophages (cell line J774)
indicate that activation of the cAMP-dependent protein kinase A (PKA) signaling pathway can inhibit RUM generation both in leukocytes [3, 4] and mitogenesis in some cell types [9] [10] [11] [12] . In leukocytes, including macrophages, an increase in intracellular cAMP can suppress the burst of RUM generation via inhibition of the NADPH oxidase, a major source of ROM in these cells [13, 14] . We have recently found that activation of the cAMP-PKA pathway suppresses RUM generation in rat glomeruli [151 as well as in primary cultured rat glomerular mesangial cells (MC) [16] .
Activation of cAMP-PKA pathway in MC also leads to the decrease of proliferation stimulated by potent mitogens [12] , albeit in a different cell compartment [16] .
In view of these observations, it is of major interest to identify endogenous activators of the cAMP-PKA pathways that may exhibit cytoprotective effects in immuno-inflammatory injury of glomerular cells. Of particular interest is a newly discovered vasoactive peptide, adrenomedullin (ADM), which was found in numerous mammalian tissues including kidney [17] . In our recent studies of dog kidney parenchyma, the presence of ADM was detected almost exclusively in glomeruli and distal segments of the nephron [18] . ADM, on a molar basis, is a singularly potent activator of cAMP-PKA pathway in rat MC [19, 20] and other cell types [21] . We previously observed that ADM inhibition of primary cultured MC proliferation is inversely correlated with in situ activation of PKA [191. Based on all these considerations, we propose a working hypothesis that ADM may play a role as intrarenal autacoid that has a prominent cytoprotective effects on pathohiologic processes in MC and in glomeruli via activation of cAMP-PKA pathway. Herein we report that in rat kidney (a)
ADM is localized in mesangium and microvessels of glomeruli, and MC can secrete ADM; (h) ADM has blocking effect upon 
METHODS

Cell culture
Mesangial cells (MC) were isolated from glomeruli and grown in a primary culture. Briefly, glomeruli were isolated from 200 g male Sprague-Dawley rats by differential sieving [12, 16, 191 , and the cell outgrowths were characterized as MC by positive immunohistochemical staining for vimentin, smooth muscle-specific actin, and negative stains for cytokeratin, factor Vili-related antigen, and leukocyte common antigen (antibodies from Dako Corp., Carpintarie, CA, USA). MC from passages 2 to 6, grown in a RPMI medium with 20% fetal calf serum (FCS), were used for determination of RUM generation, and MC from 4 to 10 passages, grown in complete Waymouth's medium with 20% FCS, were used for determination of mitogenic DNA synthesis by
[3H]-thymidine incorporation [12, 16] . Macrophages of cell line J774 were obtained from ATCC, and cells were cultured in Dulbeco-modified Eagles medium (DMEM). Vascular smooth muscle cells (VSMC) were isolated from rat thoracic aorta removed from 200 g male Sprague-Dawley rats. VSMC were outgrowths from aorta explants, as previously described [221. VSMC were grown in DMEM supplemented with 10% FCS.
VSMC were characterized, as previously [22] , by positive immunohistochemical staining for smooth muscle actin and negative stains for cytokeratin and factor Vu-related antigen (antibodies from Dako Corp.). VSMC from 4 to 10 passages were used for experiments. In all experiments cultured cells were used when they reached confluency and were rendered quiescent for 24 hours in serum-free media.
Determination of ADM synthesis in MC
Samples for determination of ADM in cell culture incubate fluid were obtained by aspiration of the medium at different time periods of incubations. Confluent MC grown in 20% FCS were washed three times with phosphate-buffered saline (PBS), and the media was replaced with DMEM without FCS and incubated without or with cytokines and growth factors at 37°C for 0 to 72 hours, as specified in the Results section. After collection, the media samples were immediately placed on ice and centrifuged 2500 rpm at 4°C for 15 minutes; the supernatants were frozen and stored at -70°C until analyzed. The samples of media (1 ml) were extracted on C-18 columns and eluted with 75% methanol containing 1% TFA [23] . Samples were concentrated by Speed-Vac and then assayed with specific and sensitive RIA for ADM (Phoenix Pharmaceuticals, Inc.), using instructions on the RIA kit.
immunohistochemical staining for ADM was performed by indirect immunoperoxidase method, as described before [18, 23] . Rat kidneys were fixed and embedded in paraffin and cut in 5 jrm sections for indirect immunoperoxidase staining, using diaminohenzidine with nickel and chromogen. After being washed, the blocks were incubated with rat polyclonal anti-ADM antiserum (Phoenix Pharmaceuticals, inc.) at a dilution of 1:800 in humidified chambers for 24 hours at room temperature, and the ADM immunohistochemical analysis was determined by standard procedure [18, 231. To determine the specificity of the ADM staining, an absorption test were performed. The anti-ADM antiserum was preincubated with 2 JLM rat ADM overnight. After centrifugation at 3000 X g for three minutes, the supernatant was used instead of the primary antiserum.
The in situ activation of PKA was determined as the ratio of PKA activity measured without added cAMP (-cAMP) to the total PKA activity measured with 1 /LM cAMP (+cAMP) and expressed as (-cAMP)/(+cAMP) PKA activity ratio as described previously [12, 15, 16, 19] . Quiescent cells in 90 mm plates were incubated at 37°C either without (control) or with different concentrations of ADM. The incubation was terminated by chilling the plates to 0 to 4°C, and MC were quickly scraped in 0.2 ml of homogenizing buffer. The scraped cells were homogenized and centrifuged at 27,000 x g for 30 minutes at 0 to 4°C. The PKA activity was determined in supernatant by incorporation of 32P-y-ATP into the oligopeptide Kemptide. The incubation was carried out for 15 to 30 minutes at 30°C with 6 g of protein per assay tube [12, 16, 19] .
[3H1 -thymidine incorporation Cell proliferation was determined by mitogenic synthesis of DNA using the [3H]-thymidine pulse-labeling assay [12, 16, 19] . MC or VSMC were plated into 24-well culture dishes at 5 X i04 cells/well and grown for 24 hours to confluence. Cells were rendered quiescent by incubation in DMEM supplemented with 0.5% FCS for 72 hours [12, 16] . After the addition of test Determination of mitogen activated protein kinase MAPK activity was determined as in our previous studies [12, 19] using the myelin basic protein (MBP) as a substrate. MC or VSMC grown in 90 mm petri dishes were rendered quiescent as described above. Cells were incubated with 10 nM ADM for 15 minutes at 37°C and then were treated with mitogens for 10 minutes. The phosphorylated MBP was determined using a paper filtration method; in preliminary control experiments we determined that the paper filtration method provides similar results as that obtained by separation MBP by SDS-PAGE and determined by autoradiography [12, 16, 19] .
Reactive oxygen metabolite generation RUM generation was measured by a microfluorometric assay using 2',5'-dichlorodihydrofluorescein diacetate as a probe [16, 24] in cells that were stimulated with serum-opsonized zymosan (SOZ) [16] . The RUM-induced fluorescence was inhibited by established RUM scavengers, that is, superoxide dismutase (SOD), catatase and dimethylthiourea [16, 24] . In the presence of SOD (40 jtg/ml) the fluorescence was blocked more than 90% [16] ; the SOD-suppressible fluorescence was considered to be due to ROM generation and is presented in the Results section. This method detects both extracellular and intracellular RUM [24] .
Statistical analysis
Statistical significance of experimental data were evaluated by ANOVA and/or Student's t-test, as appropriate. Statistical values of P < 0.05 were considered significant.
RESULTS
Localization of ADM in rat glomeruli was conducted by immunohistochemical analysis (Fig. 1) . We detected the presence of immunoreactive ADM in rat similarly to what has been found in previous studies [18] . Within glomeruli the most prominent
To determine whether ADM is produced by MC, primary staining was in the mesangium and endothelium of glomerular cultured rat MC were incubated with or without cytokines in capillaries and VSMC (Fig. 1). serum-free media, and the amount of ADM released to the . MC were incubated with various agents for 18 hours, and the ADM concentration in the cultured media was determined by RIA. Controls (Con); 10 nglml TNF-a (TNF); 10 ng/ml interleukin-1 (IL-i), 10 ng/ml platelet-derived growth factor (PDGF), 10 ng/ml epithelial growth factor (EGF). *Signiflcantly higher (by r-test) than controls. Each bar denotes mean SCM of three experiments.
culture media was determined by radioimmunoassay (RIA). ADM content in medium increased proportionally to elapsed time, without or with near-maximum doses of TNF-a ( Fig. 2A) . TNF-cs stimulated ADM release in a dose-dependent manner; the maximal increase was +625%; ED5() = 16 ng!ml (Fig. 2B) . ADM was also stimulated by IL-i, similarly as by TNF-a, whereas neither PDGF nor EGF influenced the rate of ADM production by MC (Fig. 3 ).
Next we examined the effect of ADM upon ROM generation in MC stimulated with serum opsonized zymosan (SOZ) [16] . Incubation of the MC with 10 flM ADM for 15 minutes added prior to the addition of 1 mg/mI SOZ significantly inhibited ROM generation (by -25% to 30%; Figs. 4 and 5). The inhibitory effect of ADM upon ROM generation was dose-dependent (IC50 0.5 nM; Fig. 4) . Comparison of the dose-dependent inhibition of ROM generation by ADM (Fig. 4) with dose-dependent in situ activation of PKA, assayed under similar conditions and reported previously [19] , showed a strong inverse correlation (with r -0.998, P < 0.05). Forskolin, which activates maximally cAMP- (Fig. 5) . Preincubation of the J774 macrophages for 15 minutes with ADM prior to the addition of SOZ lead to a significant (% to 19 2%; N = 5) decrease in the ROM generation (Fig. 5) , and a similar inhibition was observed in With respect to the antiproliferative actions of ADM, we compared the effect of ADM upon proliferation of MC induced by several mitogens that act via three distinct signaling pathways: PDGF, EGF, and endothelin 1 (ET-1). These mitogens were used in concentrations that stimulated MC proliferation to a similar degree, that is, about threefold (Fig. 6A) . ADM suppressed MC proliferation elicited by all three mitogens but to a different degree (Fig. 6B) . Proliferation of MC stimulated by PDGF or by EGF was suppressed dose-dependently by ADM to a similar degree, and at 10 nt ADM the inhibition was near-maximal (-80%). In contrast, the ET-1-stimulated MC proliferation was little or not inhibited at 1 nM ADM, and at 10 nM ADM the inhibition was significantly (P < 0.05) less extensive (-30%) than when proliferation of MC was stimulated by the two other mitogens (Fig. 6B ). MC were incubated with PDGF, EGF and ET-1 at concentrations that stimulated MAPK activity to a similar degree (Fig. 7A ).
ADM inhibited dose-dependently and to the same extent the MAPK stimulated by PDGF and EGF. In contrast, MAPK stimulated by ET-1 was inhibited by ADM only at the highest concentration used (10 nM) and to much lesser degree than MAPK activated by EGF and PDGF (Fig. 7B) .
Finally, we explored the effects of ADM upon mitogenesis (Fig.  8A ) and activation of MAPK (Fig. 8B) , under ambient condition when stimulated by PDGF, in cultured VSMC (Fig. 8) . In contrast to PDGF, ET-1 had only marginal mitogenic effect upon proliferation of VSMC (data not shown). Incubation of VSMC with ADM resulted in in situ activation of PKA (data not shown). Mitogenesis in VSMC was dose-dependently (IC60 0,3 nM ADM) inhibited by ADM both in the ambient state and when stimulated by PDOF (Fig. SA) . Likewise, the stimulation of PDGF by MAPK was almost completely blocked by an inclusion of 10 nrvi ADM, and the PKA inhibitor H89 reversed the inhibitory effect of ADM (Fig. SB) .
DISCUSSION
Recent studies indicate that both reactive oxygen metabolism (ROM) generation and excessive proliferation of renal cells can be inhibited by activation of the cAMP-protein kinase A (PKA) signaling pathway [12, 16, 25] . This suggests that local agonists of the cAMP pathway may play a significant role as cytoprotectors against an inflammatory insult. Results of studies presented herein provide several lines of evidence in support of our hypothesis that adrenomedullin (ADM) synthesized locally in glomerular cells exerts cytoprotective effects.
Immunoreactive ADM is present in mesangial and microvascular cells of glomeruli (Fig. 1) ; this observation is consistent with previous report that ADM is abundant in glomeruli of dog kidney [18] and that ADM can be secreted by endothelial cells and vascular smooth muscle cells (VSMC) [26, 27] . We found that mesangial cells (MC) grown in in vitro culture can secrete ADM into the media (Fig. 2) . Therefore, within glomeruli ADM may be produced not only in VSMC [26] and endothelial cells [27] but also in MC, a cell type that represents about 25% of all cells populating the glomerulus [281. It seems probable that the rate of synthesis and release of ADM in glomerular cells may be sufficient to reach ADM levels that stimulate cAMP-PKA pathways [19, 20] . ADM may thus function as an autocrine-paracrine agonist of the cAMP-PKA pathway in vivo. The rate of ADM synthesis in vitro may not quantitatively reflect in vivo conditions. Unlike its action in vitro, ADM synthesis in vivo is under the stimulatoty effect of cytokines (Fig. 3) [26] , hormones such as glucocorticoids and thyroxine [29] , and can be inhibited by cAMP-increasing agents [30] . Of interest is the fact that synthesis of ADM in MC can be stimulated by pro-inflammatory cytokines, similarly as in VAMC [26] , but not by growth factors (Fig. 3) . These observations raise the possibility that pro-inflammatory cytokine mediators of cell injury such as TNF-a and IL-i (Fig. 3) trigger the production of ADM in MC, a response that can serve as a negative-feedback protective mechanism to diminish the pathobiologic responses of MC to immune-inflammatory injury.
The exact role of ROM generated by MC in cellular mechanism of glomerular injury is not yet fully clarified. According to recent studies ROM generated in MC may not necessarily result in toxic damage [31] but may, as observed for example in smooth muscle cells [24, 32] , activate MAPK pathways, in particular the "classic" ERK pathway [321. On the other hand, the quantum of ROM generated by macrophages that infiltrate glomeruli can he substantially higher than in MC (Fig. 5) and could conceivably exert a toxic effect leading to cell death by apoptosis or necrosis; ADM inhibits ROM generation in both MC and macrophages (Fig. 5) .
ADM inhibits ROM production to a similar (%) degree as forskolin, a potent direct stimulator of adenylate cyclase that maximally activates the cAMP-PKA pathway in MC [12, 16] . This finding, as well as a close inverse correlation between the increase in in situ activity of PKA [19] and a decrease of ROM generation in MC in response to various doses of ADM (Fig. 4) , further support the notion that ADM suppresses ROM generation in MC via the cAMP-PKA pathway. Also, in macrophages ADM both inhibits ROM generation (Fig. 5 ) and activates PKA (Results). Even in the presence of a potent stimulus for cAMP generation, such as forskolin, ROM generation was only partially suppressed. This feature suggests that NADPH oxidase is only in part sensitive to inhibition by cAMP-PKA signaling pathways. We suggest that ADM can activate the cAMP-PKA pathway and thereby inhibit the assembly and activation of NADPH oxidase that is present both in MC [5] [6] [7] 161 and in macrophages [3, 33] . Since relative (%) inhibition of ROM generation in macrophages and MC by ADM is about the same (Fig. 5) , the net decrease of ROM generation in glomerulus infiltrated by macrophages would he greater due to the ADM action on macrophages.
Concerning mitogenesis, ADM inhibits MC proliferation ( acts via trimeric 0-protein [34] . However, whereas ADM suppresses profoundly and to a similar degree both MC proliferation and activation of MAPK elicited by EOF or by PDGF (Figs. 6A and 7A), the stimulation of MC proliferation and of MAPK activation by ET-i were both inhibited to a far lesser degree by ADM (Figs. 6 and 7) . A key step in the MAPK signaling pathway is the activation of raf-1 kinase [10, 11, 35] , and phosphorylation of raf-1 by PKA decreases its activity [36, 37] . Since raf-] protein kinase is an initial step in a highly amplified MAPK phosphorylation cascade [38] , even a modest decrease in activity of raf-1 can have a profound inhibitory effect upon the activation of MAPK and stimulation of mitogenesis [38] . In contrast to raf-1, the isozyme raf-A lacks a consensus sequence for PKA phosphorylation at 43Ser in the N-terminal region of the molecule [36, 39] and is slightly inhibited by the cAMP-PKA pathway [40] . We found that both raf-1 and raf-A are present in MC (analysis of extracts from MC analyzed by immunoprecipitation with specific antibodies and by Western blot showed the presence of both raf-J and raf.A; EN. Chini and T.P. Dousa, unpublished results), a finding consistent with a report of high expression of raf-A mRNA in renal tissue [41] . It is likely that ADM suppresses MC proliferation and MAPK activation [12, 19] due to an inhibition of the raf-1 via phosphorylation by activated PKA [36, 37] . While growth factors PDGF and EGF activate raf-] predominantly via a GTP-Ioaded Ras mechanism [35, 42] , ET-1 activates raf kinases via PKC phosphorylation [34, 42] at sites that are present both in raf-1 and raf-A [36, 37, 391 . Thus, ET-1 may activate both raf-1 and raf-A in MC, but only raf-1 can be inhibited via the cAMP-PKA pathway, a mechanism similar to that observed in cardiomyocytes [40] . This putative scenario suggests a tentative explanation of why ADM inhibited MAPK and mitogenesis only partially when activated by ET-1 (Figs. 6 and 7) , and should be elucidated in future studies. Interestingly, ADM was shown to suppress PDGF-stimulated synthesis of ET-1 in MC [43] . Thus, it should be considered that an elevated ADM content in glomeruli can decrease synthesis of ET-1 in MC [43] , which thereby diminishes the mitogenic stimulation of MC elicited by ET-1 via such an indirect mechanism.
Microvessels that are part of a vascular pole of the glomerulus are an important component in the regulation of glomerular functions. Injury of the renal microvessels accompanied by proliferation of VSMC is associated with a number of glomerulopathies, namely those accompanied by vasculitis or hypertension [2] .
Our findings that ADM inhibits PDGF-stimulated mitogenesis (Fig. 8A ) and MAPK activation (Fig. 8B) in VSMC, and that the inhibition was reversed by a specific PKA inhibitor similarly as in MC [12] suggest that ADM exerts antiproliferative effects, via the cAMP pathway, not only upon MC but also upon VSMC within glomeruli and/or in microvessels adjacent to glomeruli. Besides the cytoprotective effects reported herein, ADM may also conceivably act to dampen other components of pro-inflammatory processes. ADM may act as anti-migration factor [44] and can inhibit secretion of a cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family [45] . Biosynthesis of TNFa in macrophages and its release is blocked by cAMP [46, 47] ; thus, by activating the cAMP-PKA pathway ADM may suppress generation of this pro-inflammatory cytokine. In short, ADM has the potential to exert cAMP-mediated cytoprotective effects by suppressing a number of key pathobiologic components of immune-inflammatory injury in glomeruli.
In conclusion, our findings indicate that adrenomedullin (ADM) is located in the mesangial-vascular areas of glomeruli and is hiosynthesized by mesangial cells. We suggest that intraglomerular ADM can, via activation of cAMP-protein kinase A pathway, suppress several pathobiologic processes and thereby can serve in multiple ways as a cytoprotective factor, and may play 
